lck and by reconstitution approaches we demonstrate that p56 lck is required for the Notch-1-mediated activation of Akt/PKB function. Furthermore, the Src tyrosine kinase inhibitor, PP2, abrogated ectopically expressed AcN1-mediated anti-apoptotic function and phosphorylation of p56 lck . We present evidence that endogenous Notch-1 associates with p56 lck and PI3K but that Akt/PKB does not co-immunoprecipitate with the Notch1⅐p56 lck ⅐PI3K complex. Finally, we demonstrate that the Notch1⅐p56 lck ⅐PI3K complex is present in primary T cells that have been activated in vitro and sustained in culture with the cytokine interleukin-2.
Invasive cervical tumors, a major subset of human epithelial neoplasms, are characterized by the consistent presence of papillomavirus oncogenes 16 or 18 E6 and E7 products. Cervical tumors also consistently exhibit cytosolic and nuclear forms of Notch1, suggesting the possible persistent activation of the Notch pathway. Here we show that activated Notch1 synergizes with papillomavirus oncogenes in transformation of immortalized epithelial cells and leads to the generation of resistance to anoikis, an apoptotic response induced on matrix withdrawal. This resistance to anoikis by activated Notch1 is mediated through the activation of PKB/Akt, a key effector of activated Ras in transformation. We suggest that activated Notch signaling may serve to substitute for the lack of activated Ras mutations in the majority of human cervical neoplasms.
Activated Notch1 (AcN1) alleles cooperate with oncogenes from DNA tumor viruses in transformation of epithelial cells. AcN1 signaling has pleiotropic effects, and suggested oncogenic roles include driving proliferation through cyclin D1 or the generation of resistance to apoptosis on matrix withdrawal through a phosphatidylinositol 3-kinase (PI3K)-PKB/Akt-dependent pathway. Here, we extend the antiapoptotic role for AcN1 by showing inhibition of p53-induced apoptosis and transactivation. Chemical inhibitors of the PI3K pathway block AcN1-induced inhibition of p53-dependent apoptosis and nuclear localization of Hdm2. We show that expression of wild-type p53 does not inhibit synergistic transformation by AcN1 and human papillomavirus E6 and E7 oncogenes. We suggest that activation of Notch signaling may serve as an additional mechanism to inhibit wild-type p53 function in papillomavirus-associated neoplasia.
Cervical tumours evolve very slowly from precursor lesions known as dysplasias or cervical intraepithelial neoplastic (CIN) lesions, which may regress or persist (for review see Howley, 1991). Most human papillomavirus (HPV) type 16-associated cervical tumours have integrated viral DNA. Several studies have used Southern hybridizations to analyse physical state (Du$ rst et al., 1985 ;Cullen et al., 1991) and RNA in situ hybridization to examine patterns of HPV-16 gene expression. The results suggest that CIN lesions have episomes, and tumours have integrated HPV-16 genomes (for review see zur Hausen, 1991). This is also supported by a study using a PCR assay which reported the presence of episomes in all grades of CIN lesions (Das et al., 1992). This PCR assay is based on detecting disruption of the viral E2 gene, a transcription factor Author for correspondence : Betty Daniel.Fax j91 80 3343851. e-mail betty!ncbs.tifrbng.res.in which is believed to function predominantly as a repressor of the upstream regulatory region (URR) and is found to be disrupted in most cervical tumours (for review see McBride et al., 1991). The implication of detectable episomes in precursor lesions is that integration of the virus correlates with, or is the cause of, progression to invasiveness.However, on the contrary, some groups have previously used Southern hybridization as a technique to analyse physical state and reported the presence of a fair number of integrated genomes in CIN lesions (Di Luca et al., 1986 ; Lehn et al., 1988). Using the PCR assay developed by Das and colleagues, we have also previously reported that we were unable to detect episomes in high-grade CIN lesions (Daniel et al., 1995). In this paper, we have matched the PCR analysis with an RNA in situ hybridization analysis and the results support our previous assertion that the integration event is associated with the development of high-grade CIN lesions. We have also analysed changes in cytokeratins, markers of invasiveness and the Notch signal transduction pathway during the evolution of cervical lesions.The absence of amplification with primers for the E2 gene in the presence of an amplification with primers corresponding to the URR and E6 sequences correlated very well with the presence of integrated HPV-16 DNA (Das et al., 1992). In this study, we undertook a PCR analysis along with RNA in situ hybridization, using standard protocols, with fragments spanning two regions, the first covering the E6-E7 region (65-875) and the second covering the E2-E5-L2 region (3697-4761). In 15 out of 16 CIN III lesions and 19 out of 19 tumours, there were no signals detected with the E2-E5-L2 probe, while signals were detected with the E6-E7 probe in all cases. The PCR analysis showed an amplification with the URR and E6 primers and no amplification with the E2 primers in 15 out of 16 CIN III lesions and 19 out of 19 tumours (Table 1). In contrast, in CIN I\II lesions all three primer sets amplified the HPV-16 DNA fragments. Fig. 1 (a) represents an RNA in situ hybridizat...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.